Further studies should be carried out among women with PCOS with different phenotypes to segregate the role of hyperandrogenism and metabolic derangements, and clinical evaluation and metabolic parameters including those of AMH, androgens, triglycerides, high-density lipoproteins and glucose tolerance. This evidence concerns the gene AMH and polycystic ovary syndrome.